News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 722
- Sources here
- 20
- Companies here
- 16
Active search
722 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Gilead Sciences (NASDAQ: GILD) sets up automatic shelf for wide range of securities
Gilead Sciences has filed an automatic shelf registration statement on Form S-3, enabling it to offer a wide range of securities, including debt, common stock, preferred stock, and warrants, from time to time. This broad filing allows the company flexibility in future fundraising, with …
Gilat Demonstrates AI-Based Interference Detection for Resilient Satellite Links
Gilat Satellite Networks has successfully demonstrated a new AI-based interference detection and cancellation technology for satellite communication links. This patent-pending solution, which utilizes advanced AI-based signal processing, showed up to a 10x improvement in performance compared to conventional methods. The technology aims to provide …
Agilon Health Inc (AGL) News, Articles, Events & Latest Updates
Agilon Health (AGL) recently reported strong Q2 2026 earnings, exceeding revenue and EPS estimates, and increased its full-year guidance for total revenues, medical margin, and adjusted metrics. The company also announced significant savings from its ACO REACH Model for the 2024 performance year. However, …
Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Agilent Technologies (NYSE:A) secured expanded European approval for its PD-L1 IHC 22C3 pharmDx test for ovarian cancer applications. The CE-marked indication now covers patients with ovarian, fallopian …
Sharemaestro market context Trend signal started 52 weeks +3.4% · Next-week setup negative 15.8%Ermenegildo Zegna N.V. (NYSE:ZGN) Given Average Recommendation of "Moderate Buy" by Analysts
Analysts have assigned Ermenegildo Zegna N.V. (NYSE:ZGN) an average "Moderate Buy" rating, with five buy and four hold recommendations. The average 12-month price target is $13.23, which is below its current trading price of $15.18. Recent analyst actions show mixed but generally positive sentiment, …
Gilat Satellite Networks (NASDAQ:GILT) Announces Earnings Results, Beats Expectations By $0.07 EPS
Gilat Satellite Networks (NASDAQ:GILT) announced strong Q2 earnings, beating analyst expectations with an EPS of $0.20 against a $0.13 consensus and revenue increasing 17% year-over-year to $122.7 million. The company's growth was driven by substantial orders for its SkyEdge platforms and Sidewinder in-flight connectivity …
Sharemaestro market context Price below Trend Line 52 weeks +8.6%Agilysys (AGYS) holder files to resell 40,000 vested shares
A shareholder of Agilysys, Inc. (AGYS) has filed a Form 144 to sell up to 40,000 shares of common stock through Morgan Stanley Smith Barney LLC. These shares were acquired via restricted stock vesting on June 10, 2021, and the planned sale date reference …
Agilysys (AGYS) insider Ramesh Srinivasan files to sell 66,205 shares
Agilysys insider Ramesh Srinivasan has filed a Form 144 notice to sell 66,205 common shares of Agilysys, Inc. The shares, valued at approximately $7.06 million, are scheduled for sale on or after August 6, 2026, through Fidelity Brokerage Services LLC on NASDAQ. These shares …
KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments
Kymera Therapeutics, Inc. KYMR reported a second-quarter 2026 loss of 62 cents per share, narrower than the Zacks Consensus Estimate of a loss of 64 cents. The company posted a loss of 95 cents in the year-ago period. Revenues surged to $65 million from …
Why Did Ermenegildo Zegna (NYSE:ZGN) Climb to a New High?
Ermenegildo Zegna (NYSE:ZGN) is a vertically integrated luxury fashion business with global operations in retail, textile manufacturing, and premium apparel. The article notes the company's stock climbing to a new high, and provides a brief overview of its products, operational reach across various international …
Agilent Premieres 1290 Infinity III Fluorescence Detector
Agilent Technologies Inc. has launched the Agilent 1290 Infinity III Fluorescence Detector (FLD), designed to extend fluorescence detection capabilities into modern ultra-high-performance liquid chromatography (UHPLC) workflows. This new detector offers ultra-trace sensitivity, UHPLC-ready chromatographic performance, and ease of use, making it suitable for standalone …
Gildan Activewear Inc. stock rises Thursday, outperforms market
Gildan Activewear Inc. (GIL) saw its stock rise by 0.20% to C$81.60 on Thursday, outperforming the Canadian market as the S&P/TSX Composite Index fell by 0.03%. The company's stock closed 18.8% below its 52-week high of C$100.44, which was reached on February 13th.
Gilat Demos Breakthrough AI-Based Interference Detection and Cancellation Technology for Satellite Links
Gilat Satellite Networks has successfully demonstrated a new AI-based interference detection and cancellation technology for satellite communication links. This patent-pending solution, which runs on standard AI for edge NPUs, showed up to a 10x improvement in performance over conventional methods, maintaining signal quality with …
Navigating Alphabet’s (GOOGL) AI Frontier
Bronte Capital, an investment management company, released its "Amalthea Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund posted a 6.49% net return in June, bringing the quarterly returns to 5.12%, compared to 3.17% and 14.48% for …
Sharemaestro market context Trend signal started 52 weeks +3.4% · Next-week setup negative 15.8%agilon health (AGL) Is Up 16.4% After Q2 Return To Profitability And Raised 2026 Outlook
Agilon health (AGL) reported a return to profitability in Q2 2026 with net income of US$17.96 million and raised its full-year 2026 total revenue outlook to US$5.78 billion to US$5.86 billion. This positive financial performance and increased guidance support the company's margin-focused investment narrative, …
Gilat Satellite Networks Demonstrates AI-Based Interference Detection and Cancellation for Satellite Communications
Gilat Satellite Networks has successfully demonstrated its new AI-based interference detection and cancellation technology for satellite communications. This patent-pending solution offers up to a tenfold improvement in performance compared to traditional methods, enhancing reliability and service continuity in challenging spectrum environments. Gilat plans to …
Agilysys (AGYS) Could Be 17% Undervalued Following Earnings And Higher Guidance
Agilysys (AGYS) reported strong first-quarter 2026 results with increased revenue and net income, leading to raised fiscal 2027 guidance. Despite recent share price fluctuations, the stock has shown significant long-term growth. Simply Wall St's analysis suggests Agilysys is 17.2% undervalued, trading at $110.74 against …
Agilon Health Swings To Q2 Net Profit; Guides For Q3;Lifts 2026 Revenue View; Stock Gains
(RTTNews) - Agilon Health (AGL), which provides healthcare services for seniors, reported financial results for the second quarter of 2026, swinging to net profit from loss last year. In addition, the company provided revenue guidance for the third quarter and raised revenue guidance for …
How Gilat Satellite Networks Ltd. (GILT) Affects Rotational Strategy Timing
This article analyzes Gilat Satellite Networks Ltd. (GILT) using AI models to determine its effect on rotational strategy timing. It provides key findings such as strong near-term sentiment and elevated downside risk, along with institutional trading strategies tailored for different risk profiles. The analysis …
AGILON HEALTH, INC. : JEFFERIES RAISES TARGET PRICE TO $135 FROM $115
Jefferies has increased its target price for Agilon Health, Inc. from $115 to $135. This update was reported by Reuters on August 6, 2026. The article also briefly mentions other analyst target price changes and cryptocurrency prices.
Stockholder Alert: Robbins LLP Informs Investors of the Gildan Activewear Inc. Class Action
Robbins LLP has filed a securities class action lawsuit on behalf of former HanesBrands shareholders who acquired Gildan Activewear Inc. (NYSE/TSE: GIL) shares during the December 2025 cash-and-stock exchange. The lawsuit alleges that Gildan's Offering Materials contained materially false or misleading statements, specifically regarding …
Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates
Agilon Health (AGL) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $6.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Agilon Health (AGL) reported $1.49 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.2%. EPS of $1.04 for the same period compares to -$6.25 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.45 …
Agilysys, Inc. $AGYS Shares Sold by Sei Investments Co.
Sei Investments Co. reduced its stake in Agilysys, Inc. (NASDAQ:AGYS) by 17.5% in the first quarter, selling 20,667 shares but still retaining 97,298 shares valued at approximately $6.9 million. Despite this, institutional investors and hedge funds collectively own 88% of the company, and Wall …
Stronger First-Half 2026 Revenues Might Change The Case For Investing In Ermenegildo Zegna (ZGN)
Ermenegildo Zegna (ZGN) reported robust revenue growth for Q2 and the first half of 2026, with total revenues of €517.1 million and €987.3 million respectively, indicating sustained customer demand for its luxury brands. While this growth supports the company's investment narrative, challenges such as …
Amundi Makes New Investment in Ermenegildo Zegna N.V. $ZGN
Amundi has made a new investment in Ermenegildo Zegna N.V. (NYSE:ZGN), acquiring over 1 million shares valued at approximately $10.7 million. This move adds to institutional ownership, which collectively stands at 12.91% of the company's stock. The article also notes recent analyst ratings, with …
Are Options Traders Betting on a Big Move in Agilent Technologies Stock?
Investors in Agilent Technologies, Inc. A need to pay close attention to the stock based on moves in the options market lately. That is because the September 18, 2026 $85.00 Call had some of the highest implied volatility of all equity options today. What …
Sharemaestro market context Trend signal started 52 weeks +3.4% · Next-week setup negative 15.8%agilon health (NYSE:AGL) Beats Q2 CY2026 Sales Expectations, Full-Year Sales Guidance is Optimistic
Agilon Health (NYSE: AGL) reported stronger-than-expected Q2 CY2026 results, surpassing Wall Street's revenue and profit estimates. The healthcare services company also provided optimistic guidance for the next quarter's revenue and raised its full-year revenue and EBITDA forecasts, indicating positive momentum. Despite historical growth slowdowns, …
Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors
Gilead Sciences Inc. (GILD) stock fell 2.58% to $131.76 on Wednesday, underperforming compared to its competitors and ending a two-day winning streak. This occurred on a mixed trading day where the Dow Jones Industrial Average rose, but the S&P 500 Index declined.
AGL Stock Jumps As Wells Fargo Doubles Price Target
agilon health inc. (AGL) stock surged by 15.53% after Wells Fargo more than doubled its price target to $141 from $72, maintaining an Overweight rating. This optimistic outlook is fueled by AGL's strong performance in value-based care, particularly its ACO REACH entities which generated …
Arcus Biosciences (NYSE: RCUS) posts Q2 loss, ends Gilead options
Arcus Biosciences reported a Q2 2026 net loss of $91 million, or $0.72 per share, with total revenues of $41 million, a significant decrease from $160 million in Q2 2025 due to the absence of a large one-time payment from Gilead. Broad Gilead option …